Amarin (AMRN +6.6%) jumps after Jefferies (Buy) says it has learned the company would prefer...

|About: Amarin Corporation PLC (AMRN)|By:, SA News Editor

Amarin (AMRN +6.6%) jumps after Jefferies (Buy) says it has learned the company would prefer either to sell itself, or commercialize its AMR101 drug on its own, than to enter into a royalty-bearing partnership for AMR101. Management is said to be concerned about the challenges involved in negotiating a partnership.